Drug screening for Pelizaeus-Merzbacher disease by quantifying the total levels and membrane localization of PLP1.
Mol Genet Metab Rep
; 20: 100474, 2019 Sep.
Article
en En
| MEDLINE
| ID: mdl-31110947
CNS, Central nervous systems; Drug screening; EGFP, Enhanced green fluorescent protein; ER, Endoplasmic reticulum; ER-associated degradation; Gene expression; IPA, Ingenuity pathways analysis; IRE1 α, Inositol requiring enzyme 1 α; Membrane protein; Oligodendrocyte; PLP1; PLP1, Proteolipid protein 1; PMD, Pelizaeus-Merzbacher disease; UPR, Unfolded protein response; XBP1, X-box binding protein 1; msd, Myelin synthesis deficient
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Tipo de estudio:
Diagnostic_studies
/
Screening_studies
Idioma:
En
Revista:
Mol Genet Metab Rep
Año:
2019
Tipo del documento:
Article
País de afiliación:
Japón